Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Gastrointestinal Cancers
•
Medical Oncology
What treatment would you consider for rapid local recurrence of anal SCC following radiation alone in an elderly patient with borderline performance status?
Patient not deemed fit enough for APR
Related Questions
Would you include HER2 directed therapy in the treatment of HER2+ small bowel adenocarcinoma?
How do you approach patients with unresectable pancreatic cancer on gemcitabine/nab-paclitaxel-based chemotherapy q28 days with severe neutropenia?
How do you employ focal therapies in localized hepatocellular carcinoma?
In patients with active IBD and rectal cancer, do you take any precautions before starting TNT?
Is there a role for chemotherapy for asymptomatic Well-Differentiated Papillary Mesothelioma or Multicystic mesothelioma?
Is there strong evidence to use TMB found in circulating tumor DNA to guide the use of ICI in metastatic colon cancer?
Would you use adagrasib in combination with cetuximab based on recently published article in NEJM for metastatic colon cancer with KRAS G12C mutation?
Would you offer additional systemic treatment to a stage II or III resected colon cancer that received 3 months of adjuvant capecitabine/oxaliplatin and now is presenting with a solitary lung metastasis?
How would you treat a patient with a synchronous T1N2 non-small cell lung cancer and a T3N1 mid-rectal adenocarcinoma (MMR intact)?
What are best practices for oncologists during the national platinum shortage?